NuVasive gets warning letter over spinal implant marketing

03/20/2013 | MassDevice.com (Boston)

The FDA has issued a warning letter to NuVasive over certain marketing language regarding the company's Affix Spinous Process Plate System. NuVasive said in a regulatory filing that it is already beginning to address the issue, and the company stressed to its shareholders that there were no manufacturing problems that needed to be addressed.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN